Ugel S

ORCID: 0000-0002-6639-7608 · 1 paper in corpus

2015

Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.

Cancer immunology, immunotherapy : CII ·doi:10.1007/s00262-015-1747-8

Targeting the tumor vasculature with anti-angiogenesis modalities is a bona fide validated approach that has complemented cancer treatment paradigms. Tumor vasculature antigens (TVA) can be immunologically targeted and offers multiple theor…